Local News: Fairfield, WA 

 | 

Sign Up

 | 

Sign In

Advertisment

Doxorubicin (generic), Adriamycin, Doxil

Doxorubicin (generic), Adriamycin, Doxil News Editors

RoboBlogger

I edit this news page on Topix when no humans are available to help.

People just like you make Doxorubicin (generic), Adriamycin, Doxil News on Topix better every day. If you're interested in becoming an editor, apply today!

Edits History | Editor Blog

RSS icon mobile icon

Doxorubicin (generic), Adriamycin, Doxil News

News on Doxorubicin (generic), Adriamycin, Doxil continually updated from thousands of sources around the net.

Thursday Dec 3 | Nanotechnology latest papers

Single-walled carbon nanotube-conjugated chemotherapy exhibits...

HST Center for Biomedical Engineering, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Harvard-MIT Division of Health Science and Technology, Cambridge, MA 02139, USA 1 Address for correspondence: 65 Landsdowne Street, Partners Research Building, Room # 325, Cambridge, MA 02139, USA E-mail: shiladit@mit.edu Abstract.

Comment?

Related Topix: Cambridge, MA, Science / Technology, Nanotechnology, Medicine, Medication

Mon Nov 30, 2009

CiteULike

Cyclooxygenase-2 inhibitors prevent the development of...

Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression.

Comment?

Related Topix: Medicine, Health, Breast Cancer, Medication

Sat Nov 28, 2009

CiteULike

HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells.

In this study, we delineated a pathway that involves HER2/PI-3K/Akt in mediating multidrug resistance in human breast cancer cells.

Comment?

Related Topix: Pancreatic Cancer, Health, Medicine, Breast Cancer, Carac, Efudex, Fluorouracil (generic), Medication, Adrucil, Fluorouracil (generic)

Thu Nov 26, 2009

HubMed

Population-Based Analysis of the Frequency of Anemia and its...

OBJECTIVE:: In patients with hematologic malignancies, chemotherapy can further suppress bone marrow production.

Comment?

Related Topix: Lymphoma, Health, Medicine, Medication

Tue Nov 24, 2009

EurekAlert!

Gene increases effectiveness of drugs used to fight cancer and allows reduction in dosage

This release is available in French and Spanish . IMAGE: This image shows the effect of gene therapy combined with cytotoxic agents in E spheroids derived from breast cancer cell line MCF-7. A. Control; B. Doxorubicin 10nm, C. Paclitaxel 10nm,... Researchers at the University of Granada have found a suicide gene, called 'gene E', which leads to the ...

Comment?

Related Topix: Medicine, Cancer, Breast Cancer, Medication, Colorectal Health, Colon Cancer

Wed Nov 18, 2009

Medical News

CytRx plans Phase 2 clinical trial of its doxorubicin prodrug for advanced gastric cancer

CytRx Corporation , a biopharmaceutical company, today announced plans to initiate an open-label, multinational Phase 2 clinical trial with its doxorubicin prodrug INNO-206 as a second-line treatment in patients with advanced gastric cancer.

Comment?

Related Topix: Biotech, Medicine, CytRx, Healthcare Industry, Oncology, Health

Tue Nov 17, 2009

BMC Cancer

Doxorubicin Loaded Polymeric Nanoparticulate Delivery System to...

Drug resistance is a primary hindrance for the efficiency of chemotherapy against osteosarcoma.

Comment?

Related Topix: Medicine, Medication, Science / Technology, Nanotechnology

Sun Nov 08, 2009

Nature Publishing Group

Self-assembling chimeric polypeptidea "doxorubicin conjugate...

Self-assembling chimeric polypeptide-doxorubicin conjugate nanoparticles that abolish tumours after a single injection Abstract New strategies to self-assemble biocompatible materials into nanoscale, drug-loaded packages with improved therapeutic efficacy are needed for nanomedicine.

Comment?

Related Topix: Medicine, Medication

Fri Nov 06, 2009

Contract Pharma Breaking News

Ziopharm Sarcoma Trial Gets Promising Data

Ziopharm Oncology, Inc. achieved positive data from the multicenter randomized Phase II trial of palifosfamide in patients with unresectable or metastatic soft tissue sarcoma.

Comment?

Related Topix: Healthcare Law, Law, Sarcoma, Medicine, Health, Medication

GlobeNewswire

Threshold Pharmaceuticals Presents Interim Data From a Phase 1/2...

Threshold Pharmaceuticals, Inc. today announced clinical trial results related to Threshold's clinical stage hypoxia-activated prodrug, TH-302. The results were presented at the 15th Annual Connective Tissue Oncology Society Meeting taking place in Miami Beach, Florida from November 5 to 7, 2009.

Comment?

Related Topix: 9, Startups, Threshold Pharmaceuticals, Biotech, Oncology, Medicine, Miami-Beach, FL, Medication

Wed Nov 04, 2009

PhysOrg Weblog

Two-In-One Punch Knocks Out Drug Resistant Cancer Cells

Cancer cells, like bacteria, can develop resistance to drug therapy, leading to relapse of disease.

Comment?

Related Topix: Medicine, Medication, 9, Science / Technology, Nanotechnology, Physics, Science

Tue Nov 03, 2009

HubMed

Early detection of patients with poor risk diffuse large B-cell lymphoma.

More than 60% of patients with diffuse large B-cell lymphoma will be cured with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone .

Comment?

Related Topix: Cyclophosphamide (generic), Cytoxan, Medicine, Medication, Vincristine (generic), Oncovin, Vincasar

Sun Nov 01, 2009

EurekAlert!

Duke develops nano-scale drug delivery for chemotherapy

Going smaller could bring better results, especially when it comes to cancer-fighting drugs.

Comment?

Related Topix: Medicine, Medication

HubMed

Incidence and risk factors for central nervous system relapse in...

BACKGROUND: The addition of rituximab to CHOP chemotherapy improves outcome in patients with diffuse large B-cell lymphoma .

Comment?

Related Topix: Medicine, Vincristine (generic), Oncovin, Vincasar, Medication, Prednisone (generic), Deltasone, Orasone, Lymphoma, Health, Cancer

Fri Oct 30, 2009

Nucleic Acids Research

CpG methylation potentiates pixantrone and doxorubicin-induced DNA...

Tel: +61-03-9479-1517; Fax: +61-03-9479-2467; Email: s.cutts{at}latrobe.edu.au Received July 2, 2009.

Comment?

Related Topix: Medicine, Medication

Wed Oct 28, 2009

Nature Publishing Group

Activation and clinical significance of the unfolded protein response in breast cancer

Abstract Introduction: The tumour microenvironment is hypoglycaemic, hypoxic and acidotic.

Comment?

Related Topix: Medicine, Health, Breast Cancer, Oncology

Tue Oct 27, 2009

Toxicological Sciences

3-Methylindole is Mutagenic and a Possible Pulmonary Carcinogen

Fax: 585-3945. E-mail: gyost{at}pharm.utah.edu . Received April 18, 2009; accepted August 18, 2009 Abstract Previous work has shown that bioactivation of the cigarette smoke pneumotoxicant 3-methylindole by pulmonary cytochrome P450 enzymes is directly associated with formation of DNA adducts.

Comment?

Related Topix: Science, Pharmacology, University of Utah, Salt Lake City Metro, Salt Lake City, UT, Medicine, Medication

Sun Oct 25, 2009

GastroHep.com News

Cisplatin monotherapy vs cisplatin-doxorubicin for hepatoblastoma

A study in the latest issue of the New England Journal of Medicine compares cisplatin with cisplatin plus doxorubicin for standard-risk hepatoblastoma.

Comment?

Related Topix: Medicine, Medication

Fri Oct 23, 2009

Rehab Management

Doxorubicin not needed for standard-risk hepatoblastoma

Adding doxorubicin to cisplatin for standard-risk hepatoblastoma does not improve resection rates or survival in children with the disease, according to findings from the third study of the International Childhood Liver Tumor Strategy Group .

Comment?

Related Topix: Medicine, Medication, Italy, World News,

Wed Oct 21, 2009

New England Journal of Medicine

Cisplatin versus Cisplatin plus Doxorubicin for Standard-Risk Hepatoblastoma

Giorgio Perilongo, M.D., Rudolf Maibach, Ph.D., Elisabeth Shafford, M.D., Laurence Brugieres, M.D., Penelope Brock, M.D., Bruce Morland, M.D., Beatriz de Camargo, M.D., Jozsef Zsiros, M.D., Derek Roebuck, M.D., Arthur Zimmermann, M.D., Daniel Aronson, M.D., Margaret Childs, Eva Widing, M.D., Veronique Laithier, M.D., Jack Plaschkes, M.D., Jon ...

Comment?

Related Topix: Medicine, Medication, Oncology, Italy, World News,

Also on Topix